EP0728002A1 - Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen - Google Patents

Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen

Info

Publication number
EP0728002A1
EP0728002A1 EP95900830A EP95900830A EP0728002A1 EP 0728002 A1 EP0728002 A1 EP 0728002A1 EP 95900830 A EP95900830 A EP 95900830A EP 95900830 A EP95900830 A EP 95900830A EP 0728002 A1 EP0728002 A1 EP 0728002A1
Authority
EP
European Patent Office
Prior art keywords
treatment
infection
compound
hhv
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95900830A
Other languages
English (en)
French (fr)
Other versions
EP0728002B1 (de
Inventor
Richard Anthony Vere Hodge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of EP0728002A1 publication Critical patent/EP0728002A1/de
Application granted granted Critical
Publication of EP0728002B1 publication Critical patent/EP0728002B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
EP95900830A 1993-11-12 1994-11-11 Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen Expired - Lifetime EP0728002B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9323404 1993-11-12
GB939323404A GB9323404D0 (en) 1993-11-12 1993-11-12 Pharmaceuticals
PCT/GB1994/002486 WO1995013074A1 (en) 1993-11-12 1994-11-11 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection

Publications (2)

Publication Number Publication Date
EP0728002A1 true EP0728002A1 (de) 1996-08-28
EP0728002B1 EP0728002B1 (de) 2001-12-12

Family

ID=10745092

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95900830A Expired - Lifetime EP0728002B1 (de) 1993-11-12 1994-11-11 Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen

Country Status (18)

Country Link
US (1) US6051579A (de)
EP (1) EP0728002B1 (de)
JP (1) JP3821840B2 (de)
KR (1) KR100341736B1 (de)
CN (1) CN1071572C (de)
AT (1) ATE210445T1 (de)
AU (1) AU696833B2 (de)
CA (1) CA2176392C (de)
CY (1) CY2337B1 (de)
DE (1) DE69429447T2 (de)
DK (1) DK0728002T3 (de)
ES (1) ES2169117T3 (de)
GB (1) GB9323404D0 (de)
HK (1) HK1012234A1 (de)
PT (1) PT728002E (de)
SI (1) SI0728002T1 (de)
WO (1) WO1995013074A1 (de)
ZA (1) ZA948908B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475253B2 (en) 1996-09-11 2002-11-05 3M Innovative Properties Company Abrasive article and method of making
US20040097528A1 (en) * 2002-08-26 2004-05-20 Ben-Zion Dolitzky Crystalline solid famciclovir forms I, II, III and preparation thereof
EP1932911A4 (de) * 2005-09-08 2009-10-28 Univ Osaka Res Found Promotor zur einführung eines gens in lymphozyten oder blutzellen und anwendung davon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0216459B1 (de) * 1985-07-27 1990-05-16 Beecham Group Plc 9-Substituierte Guaninmonohydrate
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US4795799A (en) * 1987-09-08 1989-01-03 Phillips Petroleum Company Production of aromatic sulfide/ketone polymers with alkali metal carbonate
CA2042931A1 (en) * 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9513074A1 *

Also Published As

Publication number Publication date
DK0728002T3 (da) 2002-04-08
US6051579A (en) 2000-04-18
JP3821840B2 (ja) 2006-09-13
DE69429447D1 (de) 2002-01-24
DE69429447T2 (de) 2002-07-25
KR100341736B1 (ko) 2002-11-23
CY2337B1 (en) 2004-02-06
AU696833B2 (en) 1998-09-17
AU8149194A (en) 1995-05-29
PT728002E (pt) 2002-05-31
CN1136277A (zh) 1996-11-20
SI0728002T1 (en) 2002-04-30
CA2176392C (en) 2005-11-08
CA2176392A1 (en) 1995-05-18
HK1012234A1 (en) 1999-07-30
ES2169117T3 (es) 2002-07-01
ZA948908B (en) 1995-08-17
ATE210445T1 (de) 2001-12-15
JPH09511218A (ja) 1997-11-11
EP0728002B1 (de) 2001-12-12
CN1071572C (zh) 2001-09-26
GB9323404D0 (en) 1994-01-05
WO1995013074A1 (en) 1995-05-18

Similar Documents

Publication Publication Date Title
DK166715B1 (da) Farmaceutiske produkt og anvendelse af dette til fremstilling af et kombinationspraeparat til behandling af virusinfektioner
US6136813A (en) Pharmaceutical treatment
AU696833B2 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection
AU8103291A (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
AU690159B2 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
US6683084B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
BG63815B1 (bg) Използване на аминопуринови антивирусни средства за лечение и профилактика на латентни инфекции, причинени от херпесни вируси
EP0814813B1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
WO1996014847A1 (en) Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7)
KR100382707B1 (ko) 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도
MXPA97006759A (en) Use of penciclovir for the treatment of herpes virus 8 hum
WO1998003176A1 (en) Treatment of feline infections peritonitis by an antiviral

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960506

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 960506

RAX Requested extension states of the european patent have changed

Free format text: SI PAYMENT 960506

17Q First examination report despatched

Effective date: 20000602

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: SI PAYMENT 19960506

REF Corresponds to:

Ref document number: 210445

Country of ref document: AT

Date of ref document: 20011215

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: NOVARTIS AG

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69429447

Country of ref document: DE

Date of ref document: 20020124

ET Fr: translation filed
REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

REG Reference to a national code

Ref country code: PT

Ref legal event code: SC4A

Free format text: AVAILABILITY OF NATIONAL TRANSLATION

Effective date: 20020215

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2169117

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: EP

Ref document number: 20020400784

Country of ref document: GR

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: SI

Ref legal event code: IF

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20101110

Year of fee payment: 17

Ref country code: MC

Payment date: 20101026

Year of fee payment: 17

Ref country code: IE

Payment date: 20101110

Year of fee payment: 17

Ref country code: FR

Payment date: 20101123

Year of fee payment: 17

Ref country code: DK

Payment date: 20101110

Year of fee payment: 17

Ref country code: AT

Payment date: 20101110

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PT

Payment date: 20101108

Year of fee payment: 17

Ref country code: LU

Payment date: 20110110

Year of fee payment: 17

Ref country code: DE

Payment date: 20101104

Year of fee payment: 17

Ref country code: CH

Payment date: 20101112

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20101110

Year of fee payment: 17

Ref country code: BE

Payment date: 20101117

Year of fee payment: 17

Ref country code: IT

Payment date: 20101113

Year of fee payment: 17

Ref country code: GR

Payment date: 20101014

Year of fee payment: 17

Ref country code: SE

Payment date: 20101111

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20101217

Year of fee payment: 17

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69429447

Country of ref document: DE

Representative=s name: DR. SCHOEN, NEYMEYR & PARTNER MBB, DE

Ref country code: DE

Ref legal event code: R082

Ref document number: 69429447

Country of ref document: DE

Representative=s name: DR. SCHOEN & PARTNER, DE

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20120511

BERE Be: lapsed

Owner name: *NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD

Effective date: 20111130

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20120601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111130

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: GR

Ref legal event code: ML

Ref document number: 20020400784

Country of ref document: GR

Effective date: 20120605

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20111111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111130

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120601

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111130

REG Reference to a national code

Ref country code: SI

Ref legal event code: KO00

Effective date: 20120614

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20120731

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111130

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120605

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120511

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111111

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 69429447

Country of ref document: DE

Effective date: 20120601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111112

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111130

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111111

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111111

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 210445

Country of ref document: AT

Kind code of ref document: T

Effective date: 20111111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111111

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20130605

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20111112